299 related articles for article (PubMed ID: 24729402)
1. Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis.
Kavanaugh A; Wells AF
Rheumatology (Oxford); 2014 Oct; 53(10):1742-51. PubMed ID: 24729402
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial.
Verschueren P; De Cock D; Corluy L; Joos R; Langenaken C; Taelman V; Raeman F; Ravelingien I; Vandevyvere K; Lenaerts J; Geens E; Geusens P; Vanhoof J; Durnez A; Remans J; Vander Cruyssen B; Van Essche E; Sileghem A; De Brabanter G; Joly J; Meyfroidt S; Van der Elst K; Westhovens R
Ann Rheum Dis; 2015 Jan; 74(1):27-34. PubMed ID: 25359382
[TBL] [Abstract][Full Text] [Related]
3. Current evidence for the management of rheumatoid arthritis with glucocorticoids: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis.
Gorter SL; Bijlsma JW; Cutolo M; Gomez-Reino J; Kouloumas M; Smolen JS; Landewé R
Ann Rheum Dis; 2010 Jun; 69(6):1010-4. PubMed ID: 20448288
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoids in rheumatoid arthritis: the silent companion in the therapeutic strategy.
Berardicurti O; Ruscitti P; Pavlych V; Conforti A; Giacomelli R; Cipriani P
Expert Rev Clin Pharmacol; 2020 Jun; 13(6):593-604. PubMed ID: 32434398
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of different combinations of DMARDs and glucocorticoid bridging in early rheumatoid arthritis: two-year results of CareRA.
Stouten V; Westhovens R; Pazmino S; De Cock D; Van der Elst K; Joly J; Verschueren P;
Rheumatology (Oxford); 2019 Dec; 58(12):2284-2294. PubMed ID: 31236568
[TBL] [Abstract][Full Text] [Related]
6. Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.
Bergstra SA; Sepriano A; Kerschbaumer A; van der Heijde D; Caporali R; Edwards CJ; Verschueren P; de Souza S; Pope JE; Takeuchi T; Hyrich KL; Winthrop KL; Aletaha D; Stamm TA; Schoones JW; Smolen JS; Landewé RBM
Ann Rheum Dis; 2023 Jan; 82(1):81-94. PubMed ID: 36410794
[TBL] [Abstract][Full Text] [Related]
7. The supplementary therapeutic DMARD role of low-dose glucocorticoids in rheumatoid arthritis.
Cutolo M; Spies CM; Buttgereit F; Paolino S; Pizzorni C
Arthritis Res Ther; 2014 Nov; 16 Suppl 2(Suppl 2):S1. PubMed ID: 25608624
[TBL] [Abstract][Full Text] [Related]
8. Glucocorticoid treatment in early rheumatoid arthritis.
Krause D; Rau R; Braun J
Clin Exp Rheumatol; 2011; 29(5 Suppl 68):S121-5. PubMed ID: 22018197
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of TOcilizumab in comparison to Prednisone In Rheumatoid Arthritis patients with insufficient response to disease-modifying antirheumatic drugs (TOPIRA): study protocol for a pragmatic trial.
van der Leeuw MS; Welsing PMJ; de Hair MJH; Jacobs JWG; Marijnissen ACA; Linn-Rasker SP; Fodili F; Bos R; Tekstra J; van Laar JM
Trials; 2020 Apr; 21(1):313. PubMed ID: 32248829
[TBL] [Abstract][Full Text] [Related]
10. Controversies in rheumatoid arthritis glucocorticoid therapy.
Ruyssen-Witrand A; Constantin A
Joint Bone Spine; 2018 Jul; 85(4):417-422. PubMed ID: 29246530
[TBL] [Abstract][Full Text] [Related]
11. Patients' and rheumatologists' perspectives on the efficacy and safety of low-dose glucocorticoids in rheumatoid arthritis-an international survey within the GLORIA study.
Santiago T; Voshaar M; de Wit M; Carvalho PD; Buttgereit F; Cutolo M; Paolino S; Castelar Pinheiro GR; Boers M; Da Silva JAP
Rheumatology (Oxford); 2021 Jul; 60(7):3334-3342. PubMed ID: 33394036
[TBL] [Abstract][Full Text] [Related]
12. [Benefits and risks of glucocorticoid therapy for the treatment of rheumatoid arthritis and management of glucocorticoid-induced osteoporosis].
Suzuki Y; Wakabayashi T; Saito E; Yamada C; Suwa A
Clin Calcium; 2009 Mar; 19(3):404-15. PubMed ID: 19252251
[TBL] [Abstract][Full Text] [Related]
13. Low-dose prednisone inclusion in a methotrexate-based, tight control strategy for early rheumatoid arthritis: a randomized trial.
Bakker MF; Jacobs JW; Welsing PM; Verstappen SM; Tekstra J; Ton E; Geurts MA; van der Werf JH; van Albada-Kuipers GA; Jahangier-de Veen ZN; van der Veen MJ; Verhoef CM; Lafeber FP; Bijlsma JW;
Ann Intern Med; 2012 Mar; 156(5):329-39. PubMed ID: 22393128
[TBL] [Abstract][Full Text] [Related]
14. Does low-dose and short-term glucocorticoids treatment increase the risk of osteoporosis in rheumatoid arthritis female patients?
Korczowska I; Olewicz-Gawlik A; Trefler J; Hrycaj P; Krzysztof Łacki J
Clin Rheumatol; 2008 May; 27(5):565-72. PubMed ID: 17909741
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid safety for treating rheumatoid arthritis.
Rasch LA; Bultink IE; van Tuyl LH; Lems WF
Expert Opin Drug Saf; 2015 Jun; 14(6):839-44. PubMed ID: 25802019
[TBL] [Abstract][Full Text] [Related]
16. Effect of Glucocorticoids on the Clinical and Radiographic Efficacy of Tofacitinib in Patients with Rheumatoid Arthritis: A Posthoc Analysis of Data from 6 Phase III Studies.
Charles-Schoeman C; van der Heijde D; Burmester GR; Nash P; Zerbini CAF; Connell CA; Fan H; Kwok K; Bananis E; Fleischmann R
J Rheumatol; 2018 Feb; 45(2):177-187. PubMed ID: 29142036
[TBL] [Abstract][Full Text] [Related]
17. Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis.
Hoes JN; Jacobs JW; Buttgereit F; Bijlsma JW
Nat Rev Rheumatol; 2010 Dec; 6(12):693-702. PubMed ID: 21119718
[TBL] [Abstract][Full Text] [Related]
18. Influence of initial glucocorticoid co-medication on mortality and hospitalization in early inflammatory arthritis: an investigation by record linkage of clinical and administrative databases.
Sakellariou G; Scirè CA; Rumi F; Carrara G; Zanetti A; Cerra C; Migliazza S; Bugatti S; Montecucco C
Arthritis Res Ther; 2022 Jun; 24(1):144. PubMed ID: 35710524
[TBL] [Abstract][Full Text] [Related]
19. Glucocorticoid treatment in rheumatoid arthritis.
Rau R
Expert Opin Pharmacother; 2014 Aug; 15(11):1575-83. PubMed ID: 24856989
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoids in rheumatoid arthritis: current status and future studies.
Hua C; Buttgereit F; Combe B
RMD Open; 2020 Jan; 6(1):. PubMed ID: 31958273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
